RE:RE:RE:RE:decrease in CFFOkennethjw wrote:
Quarterly performance can always be lumpy based on payer mix, but Q1-17 was particularily soft due to an injured key physician (who is since back at work). The high margin surgeries that would have been performed during Q1-17 were rescheduled.
If that is all it takes to hurt the bottom line, that makes DR very risky indeed.
I almost hit the buy button today, but just too many negative things floating around the company right now. And I am not totally convinced they are covering the dividend, lots of fancy accounting in the "distributable cash" calculation. And of course, the ObamaCare replacement, if it ever comes, is a complete unknown.
That dividend sure is tempting, but the falling share price tells me to be cautious.
Best of luck to those that hold.